EMA Withdrawn: Alofisel (darvadstrocel) — Takeda Pharma A/S

View source ↗

Summary

The European Medicines Agency has withdrawn Alofisel (darvadstrocel) from the European market, with the product indicated for rectal fistula no longer authorize…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Fistula

Drugs mentioned

• Alofisel (darvadstrocel)

Snippet

Status: Withdrawn. Therapeutic area: Rectal Fistula. MAH: Takeda Pharma A/S. Decision date: 14/09/2023